Of the 40 patients in the PPS, 16 had ABC DLBCL, six of whom had mutant CD79B. In addition, 22 patients had GCB DLBCL, two of whom had mutant CD79B. Two patients had an unclassifiable DLBCL subtype. This evidence concerns the gene CD79B and diffuse large B-cell lymphoma.